StockData
Stevanato Group S.p.A. logo

Stevanato Group S.p.A. (STVN) stock

STVNNYSESurgical & Medical Instruments & Apparatus
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 4, 2026Score 8/30
$15.36+0.11 (+0.72%)

Close on Nov 18, 2026Market cap $4.65BP/E 27.3Yield –

Stevanato Group S.p.A. operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was €198.80M, up 23.4% from the year before. The highest annual figure on record is €200.72M in fiscal 2023.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025€198.80M+23.4%
FY2024Dec 31, 2024€161.14M-19.7%
FY2023Dec 31, 2023€200.72M+4.3%
FY2022Dec 31, 2022€192.43M+18.6%
FY2021Dec 31, 2021€162.23M+57.3%
FY2020Dec 31, 2020€103.11M+65.7%
FY2019Dec 31, 2019€62.22M–

More Stevanato Group S.p.A. figures

See a number that looks wrong?